Abstract

The safety and immunogenicity of the bivalent omicron-containing mRNA-1273.214 booster vaccine are not known.

Matéria original

Anterior

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant

Próxima

Use of low molecular weight heparin and hemoglobin fall in COVID-19 patients: A STROBE-compliant study